Neupro(R) Filed With The FDA For The Treatment Of Advanced-Stage Parkinson’s Disease
Dec 15th 2007Drug InformationParkinson's Disease
UCB announced that the supplemental New Drug Application (sNDA) for the use of Neupro(R) as adjunctive therapy with levodopa in adult patients with advanced-stage Parkinson’s disease has been accepted for filing by the U.S. Food and Drug Administration (FDA). [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
